fashion -WSS

fashion

author：Wikipedia 2025-09-06 01:58:14 - browse：21

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Why Charlie Gard's case is so disturbing to Americans

leisure time

focus

WSS

Bristol 'take

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Mom launches Girl Scout troop for LGBTQ youth in Texas

How to fix the rural physician shortage in the U.S.

Living organ donors deserve priority status for transplants

When women are denied an abortion, their children fare worse than peers

entertainment

fashion

hotspot

Peter Hotez and the public health issue of online harassment

Chemotherapy drug shortage eases slightly but still widespread

Medicare proposal to cover medical devices draws a mixed reaction

Reanimated hearts work just as well for transplants, study finds

New air purifier tech could be key to improving indoor air quality

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Medical records are filled with copy

Analysis of telehealth claims data suggest service duplication

Cancer drug shortages should be causing more outrage

Inside the rise of 'mukbang' eating videos

hotspot

Colorectal cancer study finds potential in overlooked immune cell

Reanimated hearts work just as well for transplants, study finds

Was Amgen transparent enough on FDA's concern on cancer drug?

How to fix the rural physician shortage in the U.S.

Senate panel eyes new effort on drug shortages

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

leisure time

Wikipedia

focus

Wikipedia